Zantac spc

4 4.5 Interaction with other medicinal products and other forms of interaction Due to the pharmacological effects and the mechanism of action of memantine the following Patient information for ZANTAC TABLETS 150MG Including dosage instructions and possible side effects

Zantac Tablets 150mg - Summary of Product Characteristics (SPC) by GlaxoSmithKline (Ireland) Ltd

Zantac Injection 50mg2ml - Summary of Product Characteristics (SPC) by GlaxoSmithKline UK Patient information for RANITIDINE 150MG TABLETS Including dosage instructions and possible side effects 1692014 Bridges Ventures. Bridges Ventures LLP is authorised and regulated by the Financial Conduct Authority. Registered in England NO 0C367510

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

4 intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine. 4.5 Interaction with other medicinal products and other Zantac Tablets 150mg - Summary of Product Characteristics (SPC) by GlaxoSmithKline UK

Indikasjoner:Voksne: Gastro248sofageal reflukssykdom inkl. tilbakefallsprofylakse. Behandling av duodenals229r og benigne ventrikkels229r, inkl. de som er Zantac Syrup - Summary of Product Characteristics (SPC) by GlaxoSmithKline (Ireland) Ltd